Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:EU ENCePP - Guide on Methodological Standards in Pharmacoepidemiology Revision 11 (2023) 3: Difference between revisions

From GxPlex

Jump to: navigation, search
m 1 revision imported
imported>GxPlexBot
Import from GxPlex Excel
Line 4: Line 4:
|RefDocPart=3
|RefDocPart=3
|RefLanguage=EN
|RefLanguage=EN
|RefTagsEN=
|RefTags=TAG-00033-Pro-oto
|RefTagsOriginal=
|RefModule=2
|RefTagsFR=
|RefUnit=2.1.3
}}
}}


Line 14: Line 14:
|-
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 2 — Unit 2.1.3
|-
|-
! Scope
! Scope
Line 30: Line 33:
|  
|  
|-
|-
! Tags (EN)
! Tags
|
| [[Glossary:TAG-00033-Pro-oto|Protocol]]
|-
! Tags (original language)
|
|-
! Tags (FR)
|  
|-
|-
! Comment
! Comment

Revision as of 17:29, 15 July 2026



Document information
Reference EU ENCePP - Guide on Methodological Standards in Pharmacoepidemiology Revision 11 (2023)
Validity area EU
Scope(s) INS
Document name ENCePP - Guide on Methodological Standards in Pharmacoepidemiology
Version / Revision Revision 11 (2023)
Status Current
Document type Official recommendation
Language(s) EN
Description Guide on Methodological Standards in Pharmacoepidemiology

European Network of Centres for Pharmacoepidemiology & Pharmacovigilance (ENCePP)

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 2 — Unit 2.1.3
Scope INS
Document part 3
Language EN
Original entry by Florian Adragna
Contributors
Tags Protocol
Comment Study protocol development steps

Content

3. Development of the study protocol [...]